Treatment
Adalimumab
5
Conditions
620
Trials
161K
Participants
49%
Average Safety
Condition Evidence
Ankylosing Spondylitis
68 trials · 30K participants
65% effectiveness · 60% safety
Crohn's Disease
124 trials · 25K participants
75% effectiveness · 45% safety
Psoriasis
175 trials · 30K participants
75% effectiveness · 52% safety
Pyoderma
4 trials · 500 participants
85% effectiveness · 48% safety
Rheumatoid arthritis
249 trials · 75K participants
82% effectiveness · 42% safety